1. Home
  2. AMBI vs NLSP Comparison

AMBI vs NLSP Comparison

Compare AMBI & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBI
    SELLHOLDBUYas of a day ago
  • NLSP
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • AMBI 1995
  • NLSP 2015
  • Country
  • AMBI Brazil
  • NLSP Switzerland
  • Employees
  • AMBI N/A
  • NLSP N/A
  • Industry
  • AMBI Environmental Services
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBI Industrials
  • NLSP Health Care
  • Exchange
  • AMBI Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • AMBI 290.4M
  • NLSP 6.2M
  • IPO Year
  • AMBI N/A
  • NLSP 2021
  • Fundamental
  • Price
  • AMBI $4.45
  • NLSP $2.41
  • Analyst Decision
  • AMBI
  • NLSP
  • Analyst Count
  • AMBI 0
  • NLSP 0
  • Target Price
  • AMBI N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • AMBI 11.7K
  • NLSP 2.3M
  • Earning Date
  • AMBI 01-01-0001
  • NLSP 01-21-2025
  • Dividend Yield
  • AMBI N/A
  • NLSP N/A
  • EPS Growth
  • AMBI 3161.09
  • NLSP N/A
  • EPS
  • AMBI 0.56
  • NLSP N/A
  • Revenue
  • AMBI $504,573,816.00
  • NLSP N/A
  • Revenue This Year
  • AMBI N/A
  • NLSP N/A
  • Revenue Next Year
  • AMBI N/A
  • NLSP N/A
  • P/E Ratio
  • AMBI $7.94
  • NLSP N/A
  • Revenue Growth
  • AMBI 25.13
  • NLSP N/A
  • 52 Week Low
  • AMBI $3.07
  • NLSP $1.73
  • 52 Week High
  • AMBI $8.31
  • NLSP $21.20
  • Technical
  • Relative Strength Index (RSI)
  • AMBI 36.72
  • NLSP 50.70
  • Support Level
  • AMBI $4.46
  • NLSP $2.04
  • Resistance Level
  • AMBI $6.30
  • NLSP $2.23
  • Average True Range (ATR)
  • AMBI 0.65
  • NLSP 0.33
  • MACD
  • AMBI -0.09
  • NLSP 0.10
  • Stochastic Oscillator
  • AMBI 0.00
  • NLSP 55.74

Stock Price Comparison Chart: AMBI vs NLSP

AMBI
NLSP
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022242628AMBI VS NLSP

About AMBI Ambipar Emergency Response

Ambipar Emergency Response is a environmental, emergency response and industrial field service provider in Brazil with presence in 16 countries in Latin America, North America, Europe, Africa and Antarctica. The company provides customers with a full suite of environmental services organized around prevention, training and emergency response on all transportation modes. The portfolio includes a broad variety of services such as environmental remediation, industrial field services, industrial cleaning of chemical and non-chemical products and of hazardous and non-hazardous waste, consulting services focused on accident prevention and environmental licensing.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use